Janeen GTM brain

Janeen automates benefits investigation and prior authorization workflows for infusion clinics.

category

Infusion prior authorization automation

market profile

  • text: Infusion providers must secure payer authorization for costly biologics before treatment and reimbursement.
  • text: The workflow spans referral intake, benefits checks, payer follow-up and appeals, creating multiple administrative bottlenecks.

personas

  • title: Infusion practice manager
    pains:
    • Staff time is consumed by payer forms and phone calls
    • Authorization delays hold back patient treatment and put reimbursement at risk
  • title: Prior authorization manager
    pains:
    • Requirements vary by payer, medication and diagnosis
    • Teams re-enter information and struggle to scale across locations
  • title: Clinic owner or revenue cycle leader
    pains:
    • Denials on high-cost medications can leave the provider exposed
    • Growing patient volume requires reliable access workflows

icp

  • text: US infusion clinics administering specialty biologics under buy-and-bill arrangements.
  • text: Rheumatology and headache practices with prior authorization staff and recurring infusion volume.
  • text: Multi-location clinics experiencing authorization process bottlenecks are a strong expansion fit.

message pillars

  • text: Own the full authorization process.
  • text: Follow up with insurers through a decision.
  • text: Handle the denial and appeal workload.
  • text: Give administrative time back to the clinic.

objections

  • objection: Will this work with our existing intake?
    response: Janeen says it pulls referrals from EHR or fax; verify the specific EHR and handoff in a pilot.
  • objection: What happens when a payer denies a request?
    response: The stated workflow includes appeals and deadline tracking; confirm escalation and clinical review responsibilities.
  • objection: Can we trust an automated process with expensive drugs?
    response: Start with a bounded cohort and measure payer decisions, turnaround and staff review before expanding.

competitors

  • name: CoverMyMeds
    why: Prior authorization platform identified as a competitor in coverage of the company.
  • name: eBlu Solutions
    why: Specialty medication access and prior authorization alternative listed in the market map.
  • name: Infinx
    why: Prior authorization and revenue cycle alternative listed in the market map.

influencers

  • name: Meng Fei Shen
    url: https://www.linkedin.com/posts/mengfei-shen_clinics-can-lose-money-when-prior-authorizations-activity-7421983915214548993-WQsJ
    why: Founder explains clinic denial exposure and the workflow.

keywords

  • infusion prior authorization
  • biologics benefits investigation
  • specialty medication authorization software
  • infusion clinic reimbursement
  • prior authorization appeals
  • buy and bill automation

voice

  • empathetic to clinic staff
  • plainspoken
  • personified and reassuring

signals

  • text: A clinic is opening or adding infusion locations and needs authorization capacity.
  • text: A practice is hiring prior authorization specialists or reporting payer delays and denials.

pricing

model: unknown

motion

sales_led

channels

  • LinkedIn
  • YC launch
  • SEO

confidence

medium

Founders

  • name: Meng Fei Shen
    title: Founder/CEO
    role: CEO
    bio: Founder & CEO @ Janeen (formerly Ruma Care). Previously, led Uber One global to 13M+ members and AI integrations for 100K+ suppliers at Walmart Data Ventures. Runs a 120+ person music collective in SF @juicytrees

Back to YC companies